| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.045 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |